Abstract

Hemodialysis (HD) provides life-saving treatment for kidney failure. Patient mortality is extremely high, with cardiovascular disease (CVD) being the leading cause of death. This results from both a high underlying burden of cardiovascular disease, as well as additional physiological stress from the HD procedure itself. Clinical observations indicate that HD is associated with microvascular dysfunction (MD), underlining the need for a fundamental pathophysiological assessment of the microcirculatory consequences of HD. We therefore successfully developed an experimental small animal model, that allows for a simultaneous real-time assessment of the microvasculature. Using in-house built ultra-low surface area dialyzers and miniaturized extracorporeal circuit, we successfully dialyzed male Wistar Kyoto rats and combined this with a simultaneous intravital microscopic observation of the EDL microvasculature. Our results show that even in healthy animals, a euvolemic HD procedure can induce a significant systemic hemodynamic disturbance and induce disruption of microvascular perfusion (as evidence by a reduction in the proportion of the observed microcirculation receiving blood flow). This study, using a new small animal hemodialysis model, has allowed direct demonstration that microvascular blood flow in tissue in skeletal muscle is acutely reduced during HD, potentially in concert with other microvascular beds. It shows that preclinical small animal models can be used to further investigate HD-induced ischemic organ injury and allow rapid throughput of putative interventions directed at reducing HD-induced multi-organ ischemic injury.

Highlights

  • Hemodialysis (HD) provides life-saving treatment for kidney failure

  • HD treatment improves patients’ overall health and reduces cardiovascular disease (CVD) morbidity and m­ ortality[5], a significant portion of chronic kidney disease (CKD) patients on HD will still be confronted with elevated risks to develop severe cardiovascular complications during and between dialysis treatments. this is further exacerbated by additional physiological stress from the HD procedure itself

  • These results show the technical feasibility to observe the microvasculature during a HD procedure, and functionally analyse microcirculatory blood flow

Read more

Summary

Introduction

Hemodialysis (HD) provides life-saving treatment for kidney failure. Patient mortality is extremely high, with cardiovascular disease (CVD) being the leading cause of death. This study, using a new small animal hemodialysis model, has allowed direct demonstration that microvascular blood flow in tissue in skeletal muscle is acutely reduced during HD, potentially in concert with other microvascular beds. Multimodal imaging studies during HD have confirmed a reduction in organ perfusion both early in the treatment session (blood contacting the extracorporeal circuit) and later, as a consequence of fluid removal and h­ ypotension[9,10] These early reductions in tissue perfusion occur before significant circulatory stress has been applied and in combination with observed effects of HD on children and adult patients with acute kidney injury (without a background of CKD), strongly suggest a significant effect on microcirculatory flow during the HD p­ rocedure[11,12,13]. Direct experimental visualization and quantification of MD are usually done using intravital video microscopy (IVM), allowing for a detailed visualization and investigation of the microvascular blood flow in surgically exposed tissue in a living animal, and as such, can be used to investigate the development of MD under different pathophysiological ­circumstances[27,28,29]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call